|
HS Code |
803418 |
| Chemical Name | Rhamnose |
| Other Names | 6-Deoxy-L-mannose |
| Molecular Formula | C6H12O5 |
| Molar Mass | 164.16 g/mol |
| Appearance | White crystalline powder |
| Solubility In Water | Soluble |
| Melting Point | 91-93 °C (for α-L-rhamnose monohydrate) |
| Cas Number | 3615-41-6 |
| Chirality | L-form (commonly found) |
| Taste | Mildly sweet |
| Source | Occurs naturally in plants (e.g., glycosides) |
| Stereochemistry | Exists as both α and β anomers |
| Iupac Name | 6-Deoxy-L-mannopyranose |
As an accredited Rhamnose factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Rhamnose is packaged in a 100g amber glass bottle with a screw cap, labeled with chemical details and safety information. |
| Shipping | Rhamnose is shipped in tightly sealed containers to protect it from moisture and contamination. It should be stored and transported in a cool, dry place, away from direct sunlight and incompatible substances. Proper labeling and adherence to local and international chemical shipping regulations are required to ensure safe handling and delivery. |
| Storage | Rhamnose should be stored in a tightly sealed container, protected from light and moisture, at room temperature (15–25°C). Keep it in a dry, well-ventilated area away from incompatible substances, such as strong oxidizing agents. Proper storage ensures stability and prevents degradation or contamination, maintaining the chemical’s purity and usability for laboratory or industrial applications. |
Applications of Rhamnose in Industrial ManufacturingOur company produces high-purity rhamnose, serving global industrial manufacturers in specialized downstream sectors. The following sections detail authentic application scenarios, each with regulatory compliance, practical dosage, process introduction, and typical end products. 1. Pharmaceutical Glycoside SynthesisRhamnose acts as a glycosyl donor in the synthesis of bioactive glycosides, particularly in the formulation of cardiovascular and anticancer APIs. API manufacturers select it for its role in constructing rhamnosylated compounds, which require controlled reaction conditions and precise raw material purity. The integration step typically follows strict documentation and traceability, while the quality departments monitor impurity levels, isomer ratios, and batch traceability. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Food Ingredient—Natural Flavor and Sweetener FormulationIndustrial food processors use rhamnose as a building block for manufacturing natural flavor enhancers and as a precursor for Maillard reaction-derived sweetener systems. Application includes controlled addition to jam, fruit beverage, and confectionery manufacturing. Quality assurance teams enforce food safety standards, verify allergen absence, and monitor residual sugar profiles in finished batches. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Cosmetic Active Synthesis—Anti-Aging FormulationsCosmetic ingredient manufacturers use rhamnose as a key precursor to synthesize bioactive sugar derivatives for anti-wrinkle and barrier-supportive skincare formulations. The raw material enters as a fermentation feedstock or as a direct reactant in glycosylation processes. Quality controllers check for absence of residual solvents and heavy metals, following documentation for EU and US cosmetic compliance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Precursor in Biotechnological Fermentation and Microbial ProductionBiotechnology companies utilize rhamnose as both a carbon source and an inducer in microbial culture systems, supporting recombinant protein expression and secondary metabolite production. Strict sourcing and traceability are essential, maintaining a low bioburden and meeting endotoxin limits. Process teams monitor uptake rates, metabolic conversion, and inductor-mediated gene expression profiles in bioreactor operations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Analytical Chemistry Reference and CalibrationAnalytical laboratories in the life sciences field use rhamnose as a reference standard and an internal calibrant in carbohydrate quantification and permeability assays. Laboratories require the raw material’s certificate of analysis, traceable purity, and compliance with analytical QA systems, especially for regulated bioanalytical studies and pharmacokinetic assays. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Rhamnose prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
As a manufacturer, producing high-purity monosaccharides, rhamnose has carved out a unique place in our lineup. With a steady demand across pharmaceuticals, flavors, and personal care, rhamnose stands apart from the typical glucose or fructose due to its rare L-configuration. This specific sugar isn’t just another simple carbohydrate; it brings distinct chemical and functional qualities that keep industries coming back to our facility for reliable supply.
Our daily experience shows that rhamnose’s mild sweetness and low occurrence in nature limit its direct consumption but make it an essential building block in specialty applications. The analytical labs confirm each batch aligns with strict thresholds for purity—at least 98% by HPLC. Most requests we handle require rhamnose in white crystalline powder form, scalable from kilogram pilot runs to full-scale metric-ton lots, with moisture levels tightly maintained below 1%. Such specifications reflect the real needs of users: stable storage, predictable reactivity, and minimal interference from impurities.
Consistent feedback from our long-term buyers reveals why universities, pharmaceutical companies, and flavor houses choose rhamnose over alternatives. In glycosylation chemistry, rhamnose acts as a key substrate for the synthesis of complex molecules, including glycosides with targeted biological activity. From our experience, using rhamnose as a sugar donor creates glycosides that support anti-inflammatory drug design and new antibiotics. Their trust in our supply chain grows from rigorous QA: we monitor trace metals, sulfate ash, and microbiological safety for every lot.
Manufacturers developing L-rhamnose glycosides for the food industry highlight another reason for choosing our rhamnose: it provides a base for rare flavor molecules and aroma compounds not attainable from basic sugars. Extensive scale-up projects at our site show that rhamnose’s stereochemistry and absence of bitterness simplify purification steps and lead to a more predictable finished product. We see growing adoption in the cosmetics sector as well, where rhamnose increases the responsiveness of actives in anti-aging formulas and soothing gels. Researchers shared positive feedback after running in vitro tests with our rhamnose against competitive samples; our consistent quality gave them cleaner results and less unpredictable noise.
Every technical inquiry seems to share a common need: assurance of consistent, low-impurity rhamnose. We handle requests for specialized grades—from injection-ready for pharmaceuticals to food-grade where purity, color, and slight sweetness must meet regulatory scrutiny. In our own work with downstream partners, we often see rhamnose added into targeted glycosylation projects inside pharmaceutical synthesis. Reaction yields depend directly on the optical purity of the sugar; contaminants or trace racemization complicate downstream reactions and force additional purification cycles.
Our routine partnership with research teams making lipopolysaccharide antigen standards confirms the need for tightly monitored oligosaccharide sources. Unlike other sugars in our portfolio, rhamnose usually appears in the L-form, making its production and supply chain a specialty offer. Even after years of experience, our chemists regularly calibrate equipment and review process controls to exclude D-sugar cross-contamination, keeping lot-to-lot variation at a minimum. These details aren’t just technicalities—they spell the difference between valid pharmaceutical batches and failed QC holds, between a winning research paper and a stalled project.
Clients switching from glucose or maltose to rhamnose often express surprise at the level of process control required. Rhamnose brings a distinctive stereochemistry (the L-isoform) uncommon among naturally occurring sugars used in bulk production. Where glucose suits fermentation and direct energy needs, rhamnose’s structure makes it integral for constructing particular glycosides, microbial markers, and antigenic determinants.
Lab demonstrations at our facility highlight how rhamnose’s slight methyl group at C6 disrupts common reactivity patterns. Its gentle, rounded flavor draws perfumers and flavor formulators who need a subtle sweetness rather than the more pronounced taste from typical sugars. Detailed HPLC runs show that rhamnose rarely shares physical traits, such as solubility or crystal habit, with sucrose or fructose; understanding solubility curves and hygroscopicity enables efficient recipe design in production-scale settings.
Handling and storage practices for rhamnose also diverge from other sugars. Unlike bulk glucose, which tolerates minor fluctuations in handling and humidity, rhamnose’s fine powder and high purity demand sealed, dry storage to prevent caking and maintain color. Quality assurance teams in our manufacturing division conduct regular reviews to limit degradation and track shelf-life with accelerated aging tests. Bills of material show that most products using rhamnose typically involve small yet potent doses, amplifying the impact of consistent quality from the start.
From the technical team to the scale-up unit, we recognize rhamnose users expect more than certificates of analysis and batch release notes. Regular customer site visits and troubleshooting calls highlight three repeating themes: reliable delivery timeframes, minimal packaging waste, and swift technical problem-solving. For one multinational partner developing a new glycosylated medicine, we coordinated rolling releases aligned to their pilot and production runs, minimizing downtime and cold-storage bottlenecks.
Our in-house batch records and process logs tell the story of careful scaling, from seed fermentation to downstream crystallization. Rhamnose production starts with select microbe strains capable of high-yield conversion—yeasts or bacteria known for minimal byproduct generation. Operators test for bacterial endotoxins, heavy metals, and solvent residues—especially for pharmaceutical-grade rhamnose. One oversight in these controls creates a cascade of batch failures further down the customer’s process. Years of repeated audits sharpened our response protocols and trained the team to anticipate problems well before product release.
Packing lines switched to airtight, multi-wall packets or drums with liner bags, reflecting our experience with humidity control. Users with hygroscopic or sensitive end-products opt for custom fill sizes, keeping each container open only as long as needed. These micro-adjustments directly reduce waste and improve batch traceability, which helps users clarify root causes if production issues arise.
Quality in rhamnose manufacturing stretches far beyond compliance. Maintaining tight analytical specs answers only the baseline for regulated sectors. Frequent conversations with users, R&D partners, and buyers support ongoing improvements. When several pharmaceutical users flagged trace levels of oxidizing agents in an early batch, we invested in new deoxygenated processing steps and improved inert-gas purging. Since then, external audits and returned samples routinely confirm our spec upgrades meet both USP and pharmacopoeial needs without pushing up lead times.
Batch records archive every stage of production—not only to meet GMP, but also to answer real-world “what if” scenarios. If a batch shows mild yellowing or off-phase count after shipping, our technical staff can trace back not just to raw materials, but to the precise cleaning interval of crystallizer units and packaging line humidity levels. We regularly invite major users to visit our production floor, offering a transparent overview from fermentation tanks to finished packs, to foster deeper trust.
Long-term customers often extend pilot runs or request stability data extrapolated from our archives. By collaborating at every process stage, we help users optimize their solvent systems, reaction conditions, and even downstream purification strategies. Our support team keeps plant chemists on direct line—skipping the lag time often added by intermediaries—and works with them through process deviations in real time. During product rollouts, tech staff provide hands-on support to users running unfamiliar glycosylation protocols, ensuring each run meets their precise targets.
User stories fill our meeting rooms, putting practical faces to the data. One research team, working on novel vaccine adjuvants, ran dozens of bench-scale trials before moving to multi-kilo lots. Their early runs struggled with color variability and trace impurities, hampering antigen formulation. Input from our team led to a dedicated filtration adjustment and batch-by-batch impurity maps, which gave their trials predictable results and a clean regulatory audit trail.
Another client in personal care formulated an anti-aging cream using a rhamnose-based glycoside as a bioactive. Rapid pilot batches flagged inconsistent moisture retention, traced to micro-scale variations in powder size distribution. Our process chemists modified drying protocols and updated sieving profiles to stabilize the release, which kept the downstream hydration profile exactly where their product designers needed it.
Flavor compound users pay close attention to aroma profile and Maillard reaction potential. They rely on regular batches from us to blend delicate floral or fruity notes into bakery and beverage products. On the shop floor, feedback from their blending lines inspired us to fine-tune our crystallization endpoints to prevent any burnt or “off” notes during high-temperature processing. By matching customer feedback to real-world process tweaks, we close the gap between lab outlook and commercial production reality.
Staying ahead means reviewing every new trend in applied glycosciences and fine-chemicals formulation. Global manufacturers look for sustainable, fermentation-based rhamnose instead of legacy plant hydrolysis due to lower resource impact and less batch-to-batch variability. Our process engineers collaborate with biotech researchers to refine strain selection, optimize fermentation kinetics, and reduce waste by repurposing byproducts as feedstock.
End-users in pharmaceutical synthesis increasingly request documentation of allergen, GMO, and residual solvent status. Our production teams deliver full trace reports along with standard COA documentation. Where applicable, we participate in industry consortia outlining new impurity thresholds and detection protocols, ensuring our rhamnose stays ahead of global regulatory changes. Our analytic specialists keep in close touch with third-party labs, screening for emerging contaminants and validating each analytical upgrade against gold-standard reference samples.
Ongoing investments in equipment and process automation keep output steady and labor input efficient. We scaled up automated crystallization and drying, integrating real-time sensors and process analytics for every batch. This approach addresses both volume demand and consistent spec adherence—direct benefits to customers counting on reliable, high-grade rhamnose for multi-year supply agreements.
Experts in pharmaceutical synthesis pay attention to finer details: isomeric purity, optical rotation, and reducing sugar content. For labs working on structural biology, the precise L-form of rhamnose influences protein-sugar interactions, impacting studies on glycan epitopes and immunogenicity. Our QA teams monitor for trace D-sugar content and sugar alcohols with advanced chromatography, ensuring users avoid unexpected reactivity in their experiments.
Flavorists and perfumers give practical feedback on crystallinity and hygroscopicity, impacting storage life and performance in volatile blends. Insights from these hands-on users prompted us to refine our drying and anti-caking regimes. In skin care, formulators focus on batch color, powder flow, and absence of odor-causing volatiles—all achievable due to careful production design at scale.
A few technical parameters consistently surface in customer conversations: water activity, residual solvents, color, and optical rotation. Our lab logs report tightly controlled water content below 1%, color checked via European Pharmacopeia guidelines, and optical rotation matching product spec expectations. Such fastidious attention to detail adds up in user confidence, especially in regulated supply chains.
High-purity rhamnose runs demand careful raw material sourcing and control of environmental impact. By adopting fermentation-based processes, we reduced dependence on plant extraction and its associated ecosystem disruption. Solvent use optimization and water recycling initiatives illustrate our commitment to resource conservation. Third-party audits, both routine and surprise, regularly assess our waste management and emission controls. Each improvement advances our compliance profile and reduces downstream user risks of contamination.
Workshops with regulatory experts keep our internal protocols synchronized with shifting standards in food, pharma, and cosmetic application areas. Transparency extends to providing batch documentation, allergen statements, and full production traceability to clients. This back-and-forth communication not only builds confidence but also streamlines customer audits. Our technical liaisons maintain open dialogues with global regulatory agencies, supplying timely material updates as compliance standards change.
Reducing the environmental burden aligns with both our values and business sense. By shifting to lower-impact supply partners and tightening logistics, we offer a stable price point for high-grade rhamnose despite volatility in global energy and shipping markets. Regular engagement with supply chain sustainability audits anchors us as a long-term partner for clients with strong environmental accountability targets.
Even with established process flows, challenges crop up: fermentation condition drift, unexpected crystallization behavior, or end-product trace contamination. Our manufacturing engineers keep response plans ready and consult technical stakeholders early. Last year, a rare uptick in trace acetic acid in raw fermentation liquors threatened release schedules. Immediate root-cause analysis and upstream process recalibration restored purity margins without disrupting client timelines.
Batch-to-batch traceability becomes crucial when handling recalls, compliance audits, or new regulatory demands. Instead of stacking paperwork, we deployed an integrated MES system for real-time trace logging, which has shortened our investigation time for any end-use complaint by over half. Our direct-to-customer communication channels support not only troubleshooting but also future planning: new product development, co-optimization of supply, and even joint tech pilots for next-gen rhamnose derivatives.
Cross-training production, QC, and tech support teams keeps the organization responsive and flexible. Rapid responsiveness allowed us to fulfill sudden upswings in demand from both food-tech startups and legacy pharmaceutical brands without jeopardizing quality or compliance. Such efforts build the trust that long-term customers rely on.
Customers push us to explore new applications, from advanced drug delivery glycosides to smart food ingredients with novel taste profiles. Our innovation pipeline reflects this momentum. Joint R&D projects with universities focus on expanding the functionality of rhamnose blocks in oligosaccharide synthesis and biomaterial surfaces. These collaborative discoveries feed back into tighter process controls, new production variants, and better customer options for rapid-scale deployment.
Frequent meetings with biotech innovators and formulators keep our technical teams alert to shifting needs, whether in reaction condition tolerances, impurity detection limits, or expanded trace documentation. Practical know-how—built from thousands of batches—anchors our product offerings and helps customers achieve ambitious technical and regulatory milestones.
Producing rhamnose at this level means weaving together science, reliability, and support. Each day on the production floor, chemists, engineers, and support teams come together to deliver a specialty sugar that enables cutting-edge work in pharmaceuticals, flavors, and personal care. Ongoing investment, active problem-solving, and deep partnerships define how we keep rhamnose a trusted building block for innovators worldwide.